Accéder au contenu
Merck

Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS.

Biomedical chromatography : BMC (2008-07-25)
Osama Y Al-Dirbashi, Mohamed S Rashed, Minnie Jacob, Lujane Y Al-Ahaideb, Mohamed Al-Amoudi, Zuhair Rahbeeni, Moeen M Al-Sayed, Zuhair Al-Hassnan, Mohamed Al-Owain, Hamad Al-Zeidan
RÉSUMÉ

We describe an improved diagnostic method for tyrosinemia type 1 based on quantifying succinylacetone in dried blood spots by ultra-performance liquid chromatography tandem mass spectrometry. Succinylacetone extracted from a single 3/16 inch disk of specimen collection paper containing a dried blood spot was derivatized with dansylhydrazine, separated on an Acquity UPLC BEH C(18) column (2.1 x 50 mm, 1.7 microm) and detected by electrospray ionization tandem mass spectrometry. Succinylacetone derivative eluted at 0.6 min with a complete run time of 1 min. Using a 13C4 labeled succinylacetone as an internal standard, the calibration plot was linear up to 100 micromol/L with a detection limit (S/N = 3) of 0.2 micromol/L. Intra-day (n = 13) and inter-day (n = 10) variations were better than 10%. The cutoff level of succinylacetone in dried blood spots from healthy infants obtained by the current method was 0.63 micromol/L (n = 151). In dried blood spots from patients with established tyrosinemia type 1 (n = 11), concentration of succinylacetone was 6.4-30.8 micromol/L.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dansylhydrazine, BioReagent, suitable for fluorescence, ≥90% (HPLC)